Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended References Wegovy [package insert]

Wish the tube were a bit bigger for the price, but it works
Give it a few weeks of regular use before deciding whether it's making a difference for you
[2] Whilst semaglutide does not typically cause cognitive impairment, patients taking both medications should be aware of these potential effects, which may impact daily functioning, work performance, or driving ability
Nei pazienti con insufficienza cardiaca grave (NYHA IV) Diabete mellito di tipo 1
Choose 2mL (5mg/mL) if: You are starting retatrutide for the first time Your current dose is 5mg per week or lower You want maximum measurement accuracy You prefer straightforward math Choose 1mL (10mg/mL) if: Your dose is 6mg per week or higher You want smaller injection volumes You are comfortable with precise syringe measurements You have experience reconstituting peptides Some researchers start with 2mL during their initial escalation phase and switch to 1mL once they reach maintenance doses above 4mg